Total Payments
$10,119
2024 Payments
$2,449
Companies
11
Transactions
28
Medicare Patients
694
Medicare Billing
$61,383
Payment Breakdown by Category
Consulting$7,522 (74.3%)
Food & Beverage$1,792 (17.7%)
Travel$805.71 (8.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $7,522 | 6 | 74.3% |
| Food and Beverage | $1,792 | 12 | 17.7% |
| Travel and Lodging | $805.71 | 10 | 8.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $3,269 | 4 | $0 (2023) |
| NOVARTIS PHARMACEUTICALS CORPORATION | $2,345 | 1 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $2,028 | 2 | $0 (2024) |
| GENZYME CORPORATION | $964.14 | 7 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $513.64 | 6 | $0 (2017) |
| Astellas Pharma US Inc | $309.22 | 2 | $0 (2022) |
| Telix Pharmaceuticals | $246.99 | 2 | $0 (2024) |
| EDAP TECHNOMED INC | $133.08 | 1 | $0 (2022) |
| Tempus AI, Inc | $123.12 | 1 | $0 (2024) |
| INTUITIVE SURGICAL, INC. | $100.00 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,449 | 6 | Janssen Scientific Affairs, LLC ($2,028) |
| 2023 | $3,883 | 4 | NOVARTIS PHARMACEUTICALS CORPORATION ($2,345) |
| 2022 | $1,288 | 3 | Bayer HealthCare Pharmaceuticals Inc. ($934.00) |
| 2021 | $934.00 | 1 | Bayer HealthCare Pharmaceuticals Inc. ($934.00) |
| 2019 | $551.00 | 4 | GENZYME CORPORATION ($551.00) |
| 2018 | $413.14 | 3 | GENZYME CORPORATION ($413.14) |
| 2017 | $602.33 | 7 | SANOFI-AVENTIS U.S. LLC ($513.64) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $87.12 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 09/26/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $123.12 | General |
| 07/03/2024 | Janssen Scientific Affairs, LLC | ERLEADA (Drug) | Consulting Fee | Cash or cash equivalent | $1,907.50 | General |
| Category: Oncology | ||||||
| 06/13/2024 | Janssen Scientific Affairs, LLC | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $120.34 | General |
| Category: Oncology | ||||||
| 05/04/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: SURGERY | ||||||
| 05/02/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug) | Food and Beverage | In-kind items and services | $110.46 | General |
| Category: PROSTATE CANCER DIAGNOSIS | ||||||
| 09/25/2023 | Bayer Healthcare Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $467.00 | General |
| 04/29/2023 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $136.53 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 04/20/2023 | Bayer Healthcare Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $934.00 | General |
| 03/22/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | — | Consulting Fee | Cash or cash equivalent | $2,345.00 | General |
| 11/18/2022 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $220.53 | General |
| 06/28/2022 | Bayer HealthCare Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $934.00 | General |
| 04/26/2022 | EDAP TECHNOMED INC | — | Food and Beverage | Cash or cash equivalent | $133.08 | General |
| 04/20/2021 | Bayer HealthCare Pharmaceuticals Inc. | Non-Covered | Consulting Fee | Cash or cash equivalent | $934.00 | General |
| 10/24/2019 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | In-kind items and services | $239.69 | General |
| 10/24/2019 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Food and Beverage | In-kind items and services | $190.26 | General |
| 10/24/2019 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | Cash or cash equivalent | $100.80 | General |
| 10/24/2019 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | Cash or cash equivalent | $20.25 | General |
| 10/26/2018 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Food and Beverage | In-kind items and services | $276.47 | General |
| 10/26/2018 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | Cash or cash equivalent | $100.35 | General |
| 10/26/2018 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | Cash or cash equivalent | $36.32 | General |
| 12/01/2017 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $88.69 | General |
| 10/07/2017 | SANOFI-AVENTIS U.S. LLC | NO PRODUCT DISCUSSED (Drug) | Food and Beverage | In-kind items and services | $205.34 | General |
| 10/07/2017 | SANOFI-AVENTIS U.S. LLC | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | Cash or cash equivalent | $66.44 | General |
| 10/07/2017 | SANOFI-AVENTIS U.S. LLC | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | Cash or cash equivalent | $28.02 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 151 | 155 | $44,171 | $13,076 |
| 2022 | 6 | 183 | 189 | $44,413 | $13,410 |
| 2021 | 6 | 184 | 196 | $41,505 | $13,078 |
| 2020 | 6 | 176 | 182 | $153,950 | $21,819 |
Total Patients
694
Total Services
722
Medicare Billing
$61,383
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 21 | 23 | $4,829 | $2,243 | 46.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $4,680 | $1,965 | 42.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 16 | 16 | $3,672 | $1,845 | 50.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 13 | 13 | $4,366 | $1,687 | 38.6% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 20 | 21 | $8,400 | $1,385 | 16.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 18 | $2,274 | $1,208 | 53.1% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 12 | 12 | $7,536 | $1,105 | 14.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 14 | 14 | $3,175 | $1,067 | 33.6% |
| 76377 | 3d radiographic procedure with computerized image postprocessing | Facility | 2023 | 12 | 12 | $3,336 | $316.18 | 9.5% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 11 | 11 | $1,903 | $255.40 | 13.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 50 | 55 | $7,168 | $3,344 | 46.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 18 | 18 | $5,616 | $2,291 | 40.8% |
| 55700 | Biopsy of prostate gland | Facility | 2022 | 22 | 22 | $13,816 | $2,104 | 15.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 25 | 26 | $3,684 | $1,897 | 51.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 13 | $2,412 | $1,370 | 56.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 12 | 12 | $2,073 | $1,322 | 63.8% |
| 76377 | 3d radiographic procedure with computerized image postprocessing | Facility | 2022 | 21 | 21 | $5,838 | $573.20 | 9.8% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2022 | 22 | 22 | $3,806 | $508.22 | 13.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 43 | 54 | $6,843 | $3,601 | 52.6% |
| 55700 | Biopsy of prostate gland | Facility | 2021 | 23 | 23 | $14,444 | $2,376 | 16.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 15 | 15 | $2,580 | $1,829 | 70.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 22 | 23 | $2,877 | $1,554 | 54.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 13 | 13 | $2,391 | $1,463 | 61.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 21 | 21 | $1,824 | $964.04 | 52.9% |
| 76377 | 3d radiographic procedure with computerized image postprocessing | Facility | 2021 | 23 | 23 | $6,394 | $683.33 | 10.7% |
About Dr. Simpa Salami, MD
Dr. Simpa Salami, MD is a Urology healthcare provider based in Ann Arbor, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2010. The National Provider Identifier (NPI) number assigned to this provider is 1972828192.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Simpa Salami, MD has received a total of $10,119 in payments from pharmaceutical and medical device companies, with $2,449 received in 2024. These payments were reported across 28 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($7,522).
As a Medicare-enrolled provider, Salami has provided services to 694 Medicare beneficiaries, totaling 722 services with total Medicare billing of $61,383. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Ann Arbor, MI
- Active Since 03/31/2010
- Last Updated 05/13/2019
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1972828192
Products in Payments
- ERLEADA (Drug) $2,028
- NO PRODUCT DISCUSSED (Drug) $1,478
- Non-Covered $934.00
- ILLUCCIX (Drug) $246.99
- Da Vinci Surgical System (Device) $100.00
- PYLARIFY (Drug) $87.12
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Ann Arbor
Dr. Khurshid Ghani, Md, MD
Urology — Payments: $676,971
Urology $676,971
William Roberts, Md, MD
Urology — Payments: $177,389
Urology $177,389
Bahaa Malaeb, M.d, M.D
Urology — Payments: $176,789
Urology $176,789
Casey Dauw, M.d, M.D
Urology — Payments: $137,559
Urology $137,559
Yooni Blair, Md, MD
Urology — Payments: $70,789
Urology $70,789
James Clemens, Md, MD
Urology — Payments: $56,198
Urology $56,198